How the Trump administration is working to 'combat' DEI in the private sector
What does President Donald Trump's executive order directing federal agencies to "encourage" private companies to abandon DEI ...
JPMorgan raises Ascendis Pharma target to $167, keeps Overweight
JPMorgan analyst Jessica Fye adjusted the price target for Ascendis Pharma (NASDAQ:ASND), a $7.74 billion biotech company, to $167.00, a slight increase from the previous $165.00, while reiterating ...
Analysts lift Starbucks’ stock price targets as Wall Street buys into turnaround
Wednesday as Wall Street analysts hiked their price targets for the stock and bought into upbeat comments from Chief ...